Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease
- 19 February 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 37 (3) , 775-779
- https://doi.org/10.1016/s0735-1097(00)01199-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Autoantibodies Against Oxidized LDL Do Not Predict Atherosclerotic Vascular Disease in Non–Insulin-Dependent Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Transient reduction of autoantibodies against oxidized ldl in patients with acute myocardial infarctionFree Radical Biology & Medicine, 1995
- Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic riskCoronary Artery Disease, 1993
- Autoantibody against oxidised LDL and progression of carotid atherosclerosisThe Lancet, 1992
- Role of oxidized low density lipoprotein in atherogenesis.Journal of Clinical Investigation, 1991
- Elevated serum neopterin levels in atherosclerosisAtherosclerosis, 1991
- Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989